Explore more publications!
Switzerland Weekly
Got News to Share?

Switzerland Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Weekly.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 8, 2026

SCCG Partners with ReelLink to Bring Online Casino Innovation to Land-Based Casinos and Unlock Floor Flexibility
January 8, 2026

SCCG Partners with ReelLink to Bring Online Casino Innovation to Land-Based Casinos and Unlock Floor Flexibility

Indeterminate EIN Presswire
Google Cloud joins forces with ivault to scale the first decentralized marketplace for Real World Assets
January 8, 2026

Google Cloud joins forces with ivault to scale the first decentralized marketplace for Real World Assets

Indeterminate EIN Presswire
Ferhat Kacmaz Announces New Book on Wealth Psychology and Financial Structure
January 8, 2026

Ferhat Kacmaz Announces New Book on Wealth Psychology and Financial Structure

Indeterminate EIN Presswire
IPS Group unveils Ardelin as new unified brand
January 8, 2026

IPS Group unveils Ardelin as new unified brand

Indeterminate EIN Presswire
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
January 8, 2026

MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

Indeterminate GlobeNewswire
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 8, 2026

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Santhera lizenziert AGAMREE® (Vamorolon) an Nxera Pharma in Japan, Südkorea, Australien und Neuseeland im Rahmen eines Vertrags mit einem Wert von bis zu 205 Millionen US-Dollar zuzüglich Lizenzgebühren
January 8, 2026

Santhera lizenziert AGAMREE® (Vamorolon) an Nxera Pharma in Japan, Südkorea, Australien und Neuseeland im Rahmen eines Vertrags mit einem Wert von bis zu 205 Millionen US-Dollar zuzüglich Lizenzgebühren

Indeterminate GlobeNewswire
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
January 8, 2026

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties

Indeterminate GlobeNewswire
Basilea informiert über Stand seines Portfolios und gibt Ausblick
January 8, 2026

Basilea informiert über Stand seines Portfolios und gibt Ausblick

Indeterminate GlobeNewswire
Basilea provides portfolio update and outlook
January 8, 2026

Basilea provides portfolio update and outlook

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions